Drug-labels.com

Odan-Cide: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Current status: Dormant
Strength:
100 mg / 5 mg

Patient Medication Information: uses, side effects, how to take - Odan-Cide

What is ODAN-CIDE used for?

ODAN-CIDE used to treat inflammation in the eye and to treat or prevent bacterial infection.

ODAN-CIDE contains an antibacterial ingredient called sulfacetamide sodium, and it should be used exactly as directed by your healthcare professional.

How does ODAN-CIDE work?

ODAN-CIDE contains two medicines that work together to treat your eye:

  • ° Prednisolone acetate is a corticosteroid that reduces inflammation.
  • ° Sulfacetamide sodium is an antibiotic that kills and prevents the growth of bacteria to reduce infections.

What are the ingredients in ODAN-CIDE?

Medicinal ingredients: (each ml contains) Sulfacetamide Sodium and Prednisolone Acetate.

Non-medicinal ingredients: Hydroxyethyl cellulose, polysorbate 80, sodium thiosulfate, sodium phosphate (monobasic and dibasic), edetate disodium and benzalkonium chloride 0.025% as preservative.

ODAN-CIDE comes in the following dosage forms:

  • Ophthalmic Suspension, sulfacetamide sodium 10% and prednisolone acetate 0.5%.

Do not use ODAN-CIDE if:

  • You are allergic to sulfacetamide sodium, prednisolone acetate or any of the ingredients in this product.

    You should not use ODAN-CIDE Ophthalmic Suspension if you have a viral or fungal eye infection, tuberculosis of the eye or any previous untreated eye infection.

Tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines.

The following may interact with ODAN-CIDE Ophthalmic Suspension:

  • Silver solutions.

How to take ODAN-CIDE:

  • Misuse or overuse of ODAN-CIDE could lead to the growth of bacteria that will not be killed by sulfacetamide sodium (resistance). This means that ODAN-CIDE or other medicines that contain sulfacetamide sodium may not work for you in the future.
  • Do not share your medicine.
  • Avoid touching the tip of the tube with your finger or eye to avoid contamination. Put the cap back on after use.
  • For topical use only
  • To apply:

    • Shake well before using
    • Apply 1 or 2 drops in eyelid (conjunctival sac).

Usual dose: 1 or 2 drops in eyelid every hour daily and every 2 hours at night.

When improvement occurs, the dosage may be reduced to one drop 3 or 4 times daily.

Overdose:

If you think you have taken too much ODAN-CIDE, contact your healthcare professional, hospital emergency department or regional poison control centre immediately, even if there are no symptoms.

Missed Dose:

If you forget to take ODAN-CIDE, take your dose as soon as you remember. If it is almost time for your next dose of ODAN-CIDE, skip your missed dose and take your next dose at the usual time. Do not apply double the amount to make up for your missed dose.

What are possible side effects from using ODAN-CIDE?

These are not all the possible side effects you may feel when taking ODAN-CIDE. If you experience any side effects not listed here, contact your healthcare professional.

Side effects include:

  • ° Stinging or burning sensation
  • ° Wounds taking longer to heal

Serious side effects and what to do about them

Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases
Visions changes associated with glaucoma (increased eye pressure) and/or cataracts (clouding of the lens of the eye): hazy, blurry or dim vision, eye and head pain, swelling or redness in or around the eye.✓
Vision changes associated with corneal perforation (thinning or tearing of the front of the eye): worsening of vision or loss of vision.✓
Stevens-Johnson syndrome (severe skin and mucous membrane reaction): Blisters on your skin and around your eyes, fever, red or purple rash.✓

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

Storage:

Store between 15 and 30 °C. Keep container tightly closed and protected from light.

Keep out of reach and sight of children.

If you want more information about ODAN-CIDE:

  • Talk to your healthcare professional
  • Find the full product monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada website (https://health-products.canada.ca/dpd-bdpp/index-eng.jsp); or by contacting the manufacturer, Odan Laboratories Limited at 1-800-387-9342.

Last Revised: June 27, 2019

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 00630640

Revision date stated in the text: June 27, 2019

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Odan-Cide

Rx or OTC
Prescription (Rx)?
DIN 00630640
Schedule(s) PRESCRIPTION
Active ingredient(s) Sulfacetamide sodium 100 MG, Prednisolone acetate 5 MG
Dosage form(s) Solution
Route(s) of administration Ophthalmic
Drug class (WHO ATC)
  1. S Sensory organ drugs
    1. S01 Ophthalmologicals
      1. S01C Antiinflammatory agents and antiinfectives in combination
        1. S01CA Corticosteroids and antiinfectives in combination, opthalmologic
          1. S01CA02 Prednisolone and antiinfectives
Company ODAN LABORATORIESLTD
Current status Dormant
Current status date June 22, 2017

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.